Open AccessHeart rate acceleration with GLP-1 receptor agonists in type 2 diabetes patients: an acute and 12-week randomised, double-blind, placebo-controlled trial
Author(s) -
Mark M. Smits,
Lennart Tonneijck,
Marcel H.A. Muskiet,
Trynke Hoekstra,
Mark H.H. Kramer,
Michaëla Diamant,
Daniël H. van Raalte
Publication year - 2016
Publication title -
european journal of endocrinology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.897
H-Index - 148
eISSN - 1479-683X
pISSN - 0804-4643
DOI - 10.1530/eje-16-0507
Subject(s) - medicine , liraglutide , exenatide , blood pressure , placebo , heart rate , cardiology , arterial stiffness , type 2 diabetes , vascular resistance , endocrinology , diabetes mellitus , anesthesia , alternative medicine , pathology
To examine mechanisms underlying resting heart rate (RHR) increments of GLP-1 receptor agonists in type 2 diabetes patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom